Artelo Biosciences Inc - Warrants (18/06/2024)
ARTLW
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.27M
Close$
$2.41
42919.6% upside
Current Fair Value
42919.6% upsideUndervalued by 42919.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.27 Million |
|---|---|
| Enterprise Value | $-6,251,044.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.47 |
| Beta | 1.25 |
| Outstanding Shares | 739,000 |
Return
| Return on Equity | -201.81% |
|---|---|
| Return on Assets | -107.57% |
| Return on Invested Capital | -191.05% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.31 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.49 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.12 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Artelo Biosciences Inc
3 employeesArtelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting lipid signaling pathways including the endocannabinoid system. Artelo is rap...